tiprankstipranks
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market

NeuroBo Pharmaceuticals (NRBO) Cash flow

309 Followers

NeuroBo Pharmaceuticals Cash Flow

NRBO's free cash flow for Q2 2023 was $―. For the 2023 fiscal year, NRBO's free cash flow was decreased by $3.43M and operating cash flow was $-2.04M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -8.76M$ -11.71M$ -15.13M$ -10.76M$ -7.04M$ -14.45M
Investing Cash Flow
$ -4.00K$ 8.00K$ -586.00K$ 69.00K$ -6.06M$ -3.00K
Financing Cash Flow
$ 28.60M$ 28.68M$ 22.03M$ 6.86M$ 24.17M$ 17.25M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 91.12M$ 33.36M$ 16.39M$ 10.09M$ 13.92M$ 2.85M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
---$ 0.00$ 1.00K$ 0.00
Issuance Of Capital Stock
$ 32.25M$ 32.25M$ 115.00K$ 7.50M$ 24.24M$ 16.80M
Issuance Of Debt
--$ 24.00M-$ 0.00$ 500.00K
Repayment Of Debt
-----$ -741.00K
Free Cash Flow
$ -6.72M$ -11.70M$ -15.14M$ -10.77M$ -7.25M$ -14.45M
Domestic Sales
------
Foreign Sales
------
Currency in USD

NeuroBo Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis